Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-07

Clinical Trial Update: Abortive Treatment of Migraine With the Cefaly® Abortive Program Device [NA]

View source ↗

Summary

Completed clinical trial evaluating the Cefaly Abortive Program device for migraine treatment; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefaly Abortive Program device

Snippet

Sponsor: Cefaly Technology | Conditions: Migraine | NA | Status: COMPLETED | Results posted: 2018-06-07